Fierce Life Sciences Names Inaugural AI Innovation Award Winners

Forge’s Fierce Life Sciences announced the inaugural Fierce AI Innovation Awards on September 2, 2026, recognizing AI deployments with measurable real-world effects in life sciences and healthcare.

Winners were selected by an expert judging panel for innovation, effectiveness and tangible impact across areas including drug discovery, clinical trials, manufacturing, commercial strategy and healthcare delivery.

Notable recipients include Recursion (Drug Discovery), Unlearn (Clinical Trial Design), Inato (Clinical Trial Operations), Bio-Rad Laboratories (Manufacturing & Supply Chain), Komodo Health (Commercial Strategy & Launch), Innovaccer (Data Interoperability), and Implicity (Digital Health & Diagnostics).

Other winners include Bristol Myers Squibb, Vitea, Insight Health AI, Doceree, MadeAi, Claritas Rx, Regard, Xaira Therapeutics, ViralGains, Verantos and Codoxo.

The announcement reflects a broader shift in the sector from experimental AI projects toward applications intended to improve drug development, care delivery, operational workflows and patient outcomes.